Jackson Square Partners, LLC Catalent, Inc. Transaction History

Jackson Square Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $15 Million - $23.5 Million	207,454 Added 16.59%	1,458,029 $106 Million
Q2 2022 Aug 12, 2022	SELL	$87.2 - $114.05 $17.9 Million - $23.4 Million	-205,348 Reduced 14.1%	1,250,575 $134 Million
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $4.7 Million - $6.22 Million	-49,924 Reduced 3.32%	1,455,923 $161 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $39.1 Million - $45.5 Million	326,990 Added 27.74%	1,505,847 $193 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $129 Million - $168 Million	1,178,857 New	1,178,857 $157 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Partners, LLC with notifications on news.